Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome
ConclusionsImmunotherapy within 7 days of SRS shows a possible association with improve outcomes in patients with brain metastases from melanoma.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Databases & Libraries | Immunotherapy | Melanoma | Neurology | Skin Cancer